Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [1] FLUORESCEIN ANGIOGRAPHY-GUIDED PHOTODYNAMIC THERAPY WITH HALF-DOSE VERTEPORFIN FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
    Koytak, Arif
    Erol, Kazim
    Coskun, Erol
    Asik, Nihal
    Ozturk, Hakan
    Ozerturk, Yusuf
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2010, 30 (10): : 1698 - 1703
  • [2] Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy - A pilot study
    Yannuzzi, LA
    Slakter, JS
    Gross, NE
    Spaide, RF
    Costa, DLL
    Huang, SJ
    Klancnik, JM
    Aizman, A
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2003, 23 (03): : 288 - 298
  • [3] Comparison between the outcomes of fluorescein angiography-guided and indocyanine green angiography-guided half-time photodynamic therapy for central serous chorioretinopathy
    Hayashida, Mayuka
    Miki, Akiko
    Honda, Shigeru
    Nakamura, Makoto
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2020, 31
  • [4] Comparison of Indocyanine Green Angiography and Fluorescein Angiography for Imaging of Central Serous Chorioretinopathy Patients as Candidates for Photodynamic Therapy
    Kianersi, F.
    Masjedi, M.
    Razmjoo, H.
    Ghanbari, H.
    Fazel, F.
    Dehghani, A.
    Akhlaghi, M.
    Salehi, A.
    Baghi, A.
    Pourazizi, M.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2022, 45 (03): : 338 - 343
  • [5] Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Nicolo, Massimo
    Eandi, Chiara M.
    Alovisi, Camilla
    Grignolo, Federico M.
    Traverso, Carlo Enrico
    Musetti, Donatella
    Piccolino, Felice Cardillo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (05) : 1033 - 1037
  • [6] Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Peng, Shu-Yen
    Lai, Chi-Chun
    Wang, Nan-Kai
    Wu, Wei-Chi
    Hwang, Yih-Shiou
    Chen, Kuan-Jen
    Chen, Lee-Jen
    Tsai, Shawn
    Chan, Wei-Chun
    Liu, Laura
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (06) : 466 - 472
  • [7] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
  • [8] Comparing effects of photodynamic therapy in central serous chorioretinopathy: full-dose versus half-dose versus half-dose-half-fluence
    Park, Wookyung
    Kim, Mirinae
    Kim, Rae Young
    Park, Young-Hoon
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2019, 257 (10) : 2155 - 2161
  • [9] Comparison of half-dose versus half-fluence versus standard photodynamic therapy in chronic central serous chorioretinopathy
    Altinel, Meltem Guzin
    Kanra, Ayse Yagmur
    Totuk, Ozgun Melike Gedar
    Ardagil, Aylin
    Kabadayi, Kerem
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 33
  • [10] No-Dose Photodynamic Therapy Against Half-Dose Photodynamic Therapy for Treatment of Central Serous Chorioretinopathy
    Servillo, Andrea
    Sacconi, Riccardo
    Zucchiatti, Ilaria
    Grachova, Elena
    Querques, Lea
    Prascina, Francesco
    Tombolini, Beatrice
    Dorin, Giorgio
    Mainster, Martin
    Bandello, Francesco
    Querques, Giuseppe
    OPHTHALMOLOGY AND THERAPY, 2023, 12 (04) : 2199 - 2208